Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

All TrialsPhase 2

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

LY 2189102 / Eli Lilly

NCT00380744 / 2005-002660-29: A Safety and Pharmacokinetics Study in Participants With Rheumatoid Arthritis

Completed

1b/2

121

US, Europe

LY2189102, placebo

Eli Lilly and Company

Arthritis, Rheumatoid

11/07

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites